Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic ...
Pemivibart blocks spike RBD interaction with ACE2 and received FDA EUA (Pemgarda) for pre-exposure prophylaxis in moderately to severely immunocompromised patients, not for treatment or postexposure ...
Researchers have discovered 2 leukemia stem cell subtypes with distinct epigenetic and transcriptional signatures. “Our study sets the stage to unlock new insights into the mechanisms governing ...
In a finding that challenges decades of assumptions about blood cancer, an international research team has shown for the ...
Like a creature from a science fiction movie, chronic lymphocytic leukemia (CLL) can be a shape-shifter. In a small number of cases, patients with CLL will develop lymphoma, a complication known as ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results